Walking with a twist: could blood flow cuffs rebuild strength after stroke?
NCT ID NCT06974461
First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time
Summary
This trial tests whether a special walking program using blood flow restriction (BFR) cuffs can improve muscle strength and physical function in people who have had a stroke and also have sarcopenia (age-related muscle loss). Participants will walk on a treadmill with cuffs on their thighs that partially restrict blood flow, while a comparison group does the same walking with sham cuffs. The study aims to see if this approach can boost muscle strength, muscle mass, and quality of life in chronic stroke survivors.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Blood flow restriction (BFR) walking - a supervised treadmill program with pressure cuffs on the thighs to partially restrict blood flow during exercise.
- What this could lead to
- If effective, this approach could offer a safe, practical way to improve muscle strength and physical function in stroke survivors with sarcopenia, potentially enhancing their independence and quality of life.
- What could go wrong
- This is a small, early-stage trial (64 participants) and the results may not apply to all stroke patients. BFR training carries risks like muscle soreness or rare blood clots, and the sham comparison helps test if benefits are real.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 64 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosed with chronic stroke (≥6 months post-stroke) * Sarcopenia will be diagnosed using the Asian Working Group for Sarcopenia (AWGS) 2025 criteria, defined as the concurrent presence of low muscle strength and low appendicular skeletal muscle mass. Muscle strength will be assessed using handgrip strength measured on the non-paretic side. Low muscle strength will be defined as handgrip strength \<28 kg for men and \<18 kg for women aged ≥65 years, and \<34 kg for men and \<20 kg for women aged 50-64 years. Appendicular skeletal muscle mass will be measured using bioelectrical impedance analysis, and the appendicular skeletal muscle mass index will be calculated as appendicular skeletal muscle mass divided by height squared. Low muscle mass will be defined as an appendicular skeletal muscle mass index \<7.0 kg/m² for men and \<5.7 kg/m² for women aged ≥65 years, and \<7.6 kg/m² for men and \<5.7 kg/m² for women aged 50-64 years. Exclusion Criteria: * Stroke occurred within the past 6 months * Resting systolic blood pressure \> 200 mmHg * Resting diastolic blood pressure \> 100 mmHg * Presence of implanted electronic or metallic devices that interfere with blood flow restriction cuffs * Contraindication to bioelectrical impedance analysis (e.g., pacemaker, ICD)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic stroke patients are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hong Kong Polytechnic University
NOT_YET_RECRUITINGHung Hom, Kowloon, 999077, Hong Kong
-
Hong Kong Polytechnic University
RECRUITINGHung Hom, Kowloon, 999077, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A multi-center, randomized, double-blind, placebo-controlled, phase 1/2 clinical trial to evaluate the efficacy and safety of EN001 in patients with sarcopenia
- Skeletal muscle myosin binding protein c in fatigue and aging
- Can exercise counteract Cancer's muscle wasting?
- Hidden muscle loss in Sjögren's syndrome: a new study looks for answers
- Ancient herbal formula put to the test against Age-Related muscle loss
- Lipedema and muscle loss: is there a hidden link?